TL;DR
Researchers are testing CAR T cell therapy, originally for cancer, as a potential treatment for autoimmune diseases. Early results suggest it can significantly improve symptoms, but long-term effects remain uncertain. This could transform how autoimmune conditions are managed.
Initial clinical trials of CAR T cell therapy for autoimmune diseases have shown promising results, with some patients experiencing significant symptom relief. This therapy, originally developed for certain blood cancers, is now being tested as a potential way to reset immune systems affected by autoimmune conditions. The early data suggest it could become a transformative treatment, though long-term safety and efficacy are still under investigation.
Researchers have begun applying CAR T cell therapy, which reprograms immune cells to target specific cells, to treat autoimmune diseases such as multiple sclerosis, lupus, and stiff person syndrome. The therapy involves removing a patient’s T cells, engineering them to attack problematic B cells, and reinfusing them into the patient. Early trials, including a notable study at the University of Nebraska Medical Center, have shown substantial symptom improvement in some patients, such as reduced reliance on immunotherapies and improved mobility.
For example, a trial led by Dr. Amanda Piquet at the University of Colorado evaluated CAR T therapy in patients with stiff person syndrome, a rare autoimmune disorder. Results showed that all 26 participants no longer needed other immunotherapies, and many experienced improved walking ability within 16 weeks of treatment. These findings, presented in late 2025, are among the first to demonstrate the potential of CAR T in autoimmune conditions.
Why It Matters
This development could mark a major shift in treating autoimmune diseases, which currently rely on lifelong immunosuppressive medications with significant side effects. If CAR T therapy proves safe and durable long-term, it may offer a one-time or infrequent treatment that effectively resets the immune system. This could greatly improve quality of life for millions affected worldwide and reduce healthcare costs associated with chronic management.
CAR T: A New Cure for Cancer, Autoimmune and Inherited Disease
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Background
CAR T cell therapy was first approved by the FDA in 2017 for certain blood cancers, notably leukemia. Its success in oncology has spurred interest in adapting the technology for autoimmune diseases, where the immune system mistakenly attacks the body’s own tissues. Early experiments, including a 2021 case in Germany with lupus, have shown promising results, leading to expanded trials. The approach aims to target and eliminate autoreactive B cells, which produce harmful antibodies, thereby halting disease progression.
“I think it’s a game changer for autoimmune diseases, offering hope for a more permanent solution.”
— Dr. Amanda Piquet
“I wanted to do everything possible to prevent my grandchildren from facing the same struggles I have.”
— Jan Janisch-Hanzlik
FU Autoimmune Disease Green Ribbon – Autoimmune Disease Tote Bag
For all spoonies, chargies, chronic illness warriors, and people sick and tired of being chronically ill, in chronic…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What Remains Unclear
It remains unclear how long the benefits of CAR T therapy will last in autoimmune patients and what long-term side effects might emerge. The therapy’s safety profile in this new context is still being evaluated, and larger, longer-term studies are needed to confirm efficacy and safety.
The Inflammation Spectrum: Find Your Food Triggers and Reset Your System
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
What’s Next
Researchers plan to expand clinical trials to include more patients and diverse autoimmune conditions. Long-term follow-up is underway to assess durability of response and monitor for potential adverse effects. Regulatory agencies will review emerging data to determine if broader approval is feasible.
Autoimmune Disease Autoimmune Awareness Chronic Illness Illn T-Shirt
Autoimmune Disease Awareness design for women, men, those battling Autoimmune Disease, warriors, caregivers, supporters, and medical professionals. Show…
As an affiliate, we earn on qualifying purchases.
As an affiliate, we earn on qualifying purchases.
Key Questions
How does CAR T cell therapy work for autoimmune diseases?
It involves engineering a patient’s T cells to target and eliminate autoreactive B cells responsible for attacking the body’s tissues, potentially resetting the immune system.
What are the risks of using CAR T therapy for autoimmune conditions?
Risks include potential severe inflammation, long-term immune suppression, and unknown side effects, as the therapy is still experimental in this context.
When might this treatment become widely available?
If ongoing trials confirm safety and effectiveness, regulatory approval could follow within a few years, but widespread availability depends on further research outcomes.
Can CAR T therapy cure autoimmune diseases?
It has the potential to significantly reduce symptoms or induce remission, but whether it offers a complete cure remains to be determined through ongoing research.
